CHEAPER DRUGS AT WHAT COST?
New research reveals that generic medications are more frequently recalled than brand-name drugs, raising concerns about safety in the push for lower prices. A study led by Kaitlin D. Wowak and her co-authors analyzed over 900 pharmaceutical recalls from 2002 to 2014, finding that generic drugs produced by multiple manufacturers faced higher recall rates compared to brand-name counterparts, which are made by single producers. This trend highlights potential risks associated with less regulatory scrutiny and manufacturing practices in the generic drug industry.
- Published
- Author
- Michael Hardy
Related News & Stories

Vita
PHOTO OPS
Natural Baptiste, a first-generation college student and double major, reflects on his time at Notre Dame, noting the challenges of a virtual graduation. In remote learning updates, finance professor Walter Clements adapted his teaching methods to accommodate 67 MBA students through Zoom. Celebrating International Women's Day, Hong Guo was highlighted in the Women Lead profile series, while Ethics Week concluded with a panel on women in the workplace. Amid the pandemic, Indiana Whiskey Company pivoted from whiskey production to hand sanitizer, responding to the pressing local need.

Vita
Research: REMOTE POSSIBILITIES
As remote work becomes increasingly common, effective collaboration is essential for teams spread out across the globe. Insights from Mendoza College of Business professor Nicholas Berente offer practical tips to enhance virtual teamwork, emphasizing the importance of clearly defined goals and structured communication. The piece outlines strategies to improve efficiency in remote collaboration, highlighting how focused planning and the right use of digital tools can significantly impact team dynamics.

Vita
Research: PUBLIC v PRIVATE
Amid a rising trend of companies opting to remain private or delist from major stock exchanges, new research sheds light on the ongoing debate over public versus private ownership. Professor Brad Badertscher and his colleagues from the Mendoza College of Business analyzed the future profitability of publicly traded firms compared to privately held ones. Findings indicate that private firms often outperform their public counterparts in operating profitability over a five-year period, suggesting that fewer pressures for short-term earnings can benefit long-term growth strategies.
Wowak and her co-authors examined 939 pharmaceutical recalls across 64 firms from 2002 to 2014. Using data from the FDA's annual Orange Book, which tracks all approved medications in the United States, the researchers found that generic drugs with multiple manufacturers were recalled more frequently than brand-name drugs that were manufactured under a monopoly.